Fibroblastový růstový faktor-2
[Fibroblast growth factor-2]
Language Czech Country Czech Republic Media print
Document type English Abstract, Journal Article, Review
PubMed
15702865
- MeSH
- Fibroblast Growth Factor 2 chemistry pharmacology physiology MeSH
- Neovascularization, Physiologic physiology MeSH
- Hematopoiesis physiology MeSH
- Humans MeSH
- Myeloproliferative Disorders physiopathology MeSH
- Receptors, Fibroblast Growth Factor metabolism MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- English Abstract MeSH
- Journal Article MeSH
- Review MeSH
- Names of Substances
- Fibroblast Growth Factor 2 MeSH
- Receptors, Fibroblast Growth Factor MeSH
Fibroblast growth factor-2 is a member of a large family of proteins that bind heparin and heparan sulfate and modulate the function of a wide range of cell types. FGF-2 occurs in several isoforms resulting from alternative initiations of traslation: an 18 kDa cytoplasmic isoform and four larger molecular weight nuclear isoforms (22, 22.5, 24 and 34 kDa). It acts mainly through a paracrine/autocrine mechanism involving high affinity transmembrane receptors and heparan sulfate proteoglycan low affinity receptors. It is expressed mostly in tissues of mesoderm and neuroectoderm origin, and plays an important role in mesoderm induction, stimulates the growth and development of the new blood vessels (angiogenesis), normal wound healing and tissue development. FGF-2 positively regulates hematopoiesis by acting on various cellular targets: stromal cells, early and committed hematopoietic progenitors and possibly some mature blood cells. FGF-2 is a potent hematopoietic growth factor that is likely to play an important role in physiological and pathological hematopoiesis.